{
  "Variants Include": [
    {
      "Gene": " parksin",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "a-synuclein gene mutations A30P, A53T and E46K were described as the cause of familial forms of Parkinson's disease and dementia with Lewy bodies. Missense mutations (A30P) in a-synuclein have been shown to be the major component of the abnormal filamentous inclusions."
        }
      ]
    },
    {
      "Gene": " parksin",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "a-synuclein gene mutations A30P and E46K were described as the cause of familial forms of Parkinson's disease and dementia with Lewy bodies. Missense mutations (A53T) in a-synuclein have been shown to be the major component of the abnormal filamentous inclusions."
        }
      ]
    },
    {
      "Gene": " parksin",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "a-synuclein gene mutations A30P, A53T and E46K were described as the cause of familial forms of Parkinson's disease and dementia with Lewy bodies. Missense mutations (E46K) have been shown to be the major component of the abnormal filamentous inclusions."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Familial forms of Parkinson's disease, Dementia with Lewy bodies, and Movement disorders associated with parkinsonism",
    "MONDO": "N.D."
  },
  "Experiment Method": [
    {
      "Assay Method": "N.D.",
      "Material used": {
        "Material Source": "N.D.",
        "Material Name": "N.D.",
        "Description": "N.D."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Source": "Literature/Custom"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Literature/Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Literature/Custom"
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    }
  ]
}